Discover why less than 20% of clinical research uses adaptive trial designs despite their efficiency, flexibility, and ethical benefits. Learn about the challenges, benefits, and strategies to increase adoption
Adaptive trial designs have been game-changers in the clinical research world for one simple reason. They provide an unrivaled degree of flexibility and efficiency. Yet, fewer than 20% of clinical studies are using these technology-based methods, despite their tremendous benefits. This post will describe the reasons for which this approach is so scarcely used, along with some of the advantages and challenges related to these designs.
Introduction to Adaptive Trial Designs
A unique challenge in Clinical research is its use of the adaptive trial design that enables alteration of trial procedures (such as dose adjustment, sample size re-estimation or patient stratification) based on interim results. This adaptive workflow as opposed to the conventional fixed model comes with a number of advantages such as lower costs, shorter trial times and more ethical feasibility by potentially requiring fewer subjects.
Adaptive trial designs – the advantages
Greater flexibility with the ability to refine the study design based on preliminary data.
Efficiency: Rapid completion of trials when the drug or drugs are found to be ineffective.
Ethical concerns: Less possibly unwarranted treatment for the individual patient.
Resource Allocation: Resources may be more effectively applied to promising treatments
Reasons for Under Utilization
While these advantages make adaptive trial designs highly valuable, there are a host of challenges that have contributed to their smaller adoption.
Complicated: Adaptive trials are more complex than traditional trials in terms of designing, implementing and analyzing.
Regulatory Hurdles: Adaptive trials can be tricky with regulatory leading toreduced patient burden and lost opportunity.
Statistical expertise: A deeper level statistical knowledge is necessary to design and analyze adaptive trials.
The Benefits of Conservative Mindsed: Many researchers and sponsors are comfortable with traditionalmethodologies.
Infrastructure: Adaptive trial designs often require the establishment of specific infrastructure by research institutions.
Trial Design of the Future
Essential steps to the adoption of adaptive trial designs
Encourage wider familiarity and acceptability by key stakeholders on adaptive trial design through education and training of researchers and the sponsoring health agencies.
Regulatory harmonization: This is about making it easier to run adaptive trials, with uniform regulatory requirements across the board.
Statistical Support: Improved statistical access and tools for adaptive trial design and analysis
Building infrastructure: Investing in the infrastructure needed to accommodate adaptive trial approaches
Changing Culture: Promoting a cultural shift towards acceptance of novel trial designs with enhanced flexibility.
Conclusion: Why Adaptive Trial Designs Are Essential for the Future of Clinical Trials
Adaptive trial designs are a game-changer for clinical research, but they are employed by <20% of the studies conducted. Such barriers to their adoption will need to be addressed, potentially through educational and regulatory support for research that desire a transition, but doing so can increase the efficiency of clinical research. Just as the biotech and pharmaceutical consulting firms in Boston have shown, employing knowledgeable expertise can really lift adaptive trial designs to improve health outcomes and fast track medical innovation.
Contact BioBoston Consulting now or go through our website to understand how we can help your company.
